Medical Oncology Partners (Tables)

6 Months Ended

Jun. 30, 2019

Medical Oncology Partners LLC [Member]

Schedule of Equity Method Investments [Line Items]

Equity Method Investment Summarized Financial Information

The following table presents the summarized financial information of MOP:

MOP Condensed Consolidated Income Statement Information

	Six Months Ended June 30,
	2019			2018
Patient revenue	$	1,347,000		$	1,057,000
Net loss	$	(103,000	)	$	(136,000	)
USNC's equity in loss in MOP	$	(37,000	)	$	(49,000	)

	Three Months Ended June 30,
	2019			2018
Patient revenue	$	737,000		$	537,000
Net loss	$	(65,000	)	$	(119,000	)
USNC's equity in loss in MOP	$	(23,000	)	$	(43,000	)

MOP Condensed Consolidated Balance Sheet Information

	June 30, 2019			December 31, 2018
Current assets	$	193,000		$	41,000
Noncurrent assets		214,000			159,000
Total assets	$	407,000		$	200,000
Current liabilities	$	1,326,000		$	1,002,000
Noncurrent liabilities		19,000			33,000
Deficit		(938,000	)		(835,000	)
Total liabilities and equity	$	407,000		$	200,000